Effusion cytology of malignant mesothelioma enables earlier diagnosis and recognizes patients with better prognosis.

Abd Own, Sulaf; Höijer, Jonas; Hillerdahl, Gunnar; Dobra, Katalin; Hjerpe, Anders

Abd Own, Sulaf; Höijer, Jonas; Hillerdahl, Gunnar; Dobra, Katalin; Hjerpe, Anders.

Afiliação

Abd Own S; Department of Laboratory Medicine, Division of Pathology, Karolinska University Hospital, Stockholm, Sweden.
Höijer J; Unit of Biostatistics, Institute of Environmental Medicine, Karolinska Institute, Stockholm, Sweden.
Hillerdahl G; Department of Pulmonary Diseases, Karolinska University Hospital, Stockholm, Sweden.
Dobra K; Department of Laboratory Medicine, Division of Pathology, Karolinska University Hospital, Stockholm, Sweden.
Hjerpe A; Department of Laboratory Medicine, Division of Pathology, Karolinska University Hospital, Stockholm, Sweden.

Diagn Cytopathol ; 49(5): 606-614, 2021 May.

Article em En | MEDLINE | ID: mdl-32049443

Assuntos

Mesotelioma Maligno/diagnóstico; Derrame Pleural Maligno/patologia; Neoplasias Pleurais/diagnóstico; Adulto; Idoso; Citodiagnóstico/métodos; Feminino; Humanos; Masculino; Pessoa de Meia-Idade; Estudos Retrospectivos

Palavras-chave

cytology; effusion; histology; malignant mesothelioma; survival time

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pleurais / Derrame Pleural Maligno / Mesotelioma Maligno Tipo de estudo: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google